HORMONES
Gynaecomastia Blood Test UK: The Hormones Behind Male Breast Tissue
QUICK ANSWER
True gynaecomastia is enlarged glandular breast tissue in men, usually caused by a shift in the balance between oestrogen and testosterone. The blood tests most worth checking are oestradiol, total and free testosterone, SHBG, prolactin, LH, FSH, thyroid and liver function. A new, painful or one-sided lump should always be reviewed by a qualified clinician.
Noticing breast tissue you did not have before is unsettling, and it is one of the harder things for a man to raise with anyone. It is also extremely common. Gynaecomastia — the medical term for enlarged male breast tissue — affects a large share of men at some point in life, with peaks in the newborn period, puberty and again from middle age onward. Most of the time it is benign. But because it is so often driven by hormones, it is one of the few visible signs that the body’s endocrine balance has shifted, and that makes it worth understanding rather than hiding.
The first job is to separate two things that look similar in the mirror: real glandular tissue and simple fat. The second is to work out why the gland has grown, because the answer ranges from completely harmless to occasionally important. A focused blood test is the cleanest way to see the hormonal picture behind it. This guide covers what the gland is responding to, which markers matter, the red flags that mean you should not wait, and what to do with your results.
By Helvy · Medically reviewed by a qualified clinician · 12 min read
1. Real gynaecomastia or just chest fat?
The single most useful distinction is between true gynaecomastia and what doctors call pseudogynaecomastia. True gynaecomastia is growth of the firm glandular tissue that sits directly behind the nipple. Pseudogynaecomastia is excess fat across the chest with no gland enlargement, which is common with higher body fat and tends to soften and spread evenly rather than form a disc. The NHS guidance on gynaecomastia describes the glandular type as a rubbery or firm mound felt under the nipple, sometimes tender, and sometimes on one side only.
A rough self-check that clinicians use: pinch the tissue between finger and thumb, working in toward the nipple. True glandular tissue feels like a distinct, firmer disc concentrated under the areola, while fat feels uniform and soft and is not centred on the nipple. This is only a guide, not a diagnosis — a clinical examination settles it — but it explains why two men with similar-looking chests can have completely different causes and need different next steps.
Why does the distinction matter for a blood test? Because true glandular gynaecomastia is the type most likely to be responding to a hormonal signal, and that signal is exactly what blood markers can reveal. Pseudogynaecomastia, by contrast, usually tracks with body fat and the metabolic markers that go with it.
2. Why it happens: the oestrogen-to-testosterone balance
Breast tissue is exquisitely sensitive to the ratio between oestrogen and androgens. Oestrogen stimulates the gland to grow; testosterone and other androgens hold that growth in check. Men make small amounts of oestrogen normally, much of it converted from testosterone by an enzyme called aromatase, which is especially active in fat tissue. Gynaecomastia develops when that balance tips toward oestrogen — either because oestrogen rises, testosterone falls, or the ratio between them shifts. The review by Narula and Carlson in the Indian Journal of Endocrinology and Metabolism frames this oestrogen-to-androgen imbalance as the common final pathway for almost every cause.
This is why two facts often surprise men. First, carrying more body fat is itself a driver, because fat tissue converts more testosterone into oestrogen — the imbalance and the appearance can feed each other. Second, low testosterone produces gynaecomastia not because oestrogen is high in absolute terms, but because the restraining signal has weakened and the ratio has moved. A single oestrogen number in isolation can therefore look unremarkable; it is the relationship between the hormones that tells the story.
The practical implication is that a useful blood test does not chase one marker. It measures oestradiol and testosterone together, along with the proteins and pituitary signals that govern them, so the balance — not just the individual values — can be read.
3. The blood tests that matter
There is no single “gynaecomastia test”. A sensible panel captures the hormonal balance and the systems that can disturb it. The StatPearls clinical review of gynaecomastia recommends a workup that looks at the sex hormones, the pituitary signals above them, and thyroid, liver and kidney function. A morning sample is best, because testosterone peaks before 10am.
| Marker | What it tells you | System |
|---|---|---|
| Oestradiol | The main oestrogen in men — the signal that drives gland growth when it runs high relative to testosterone | Hormonal |
| Total testosterone | Low levels weaken the androgen restraint on breast tissue | Hormonal |
| Free testosterone | The active fraction — can be low even when total testosterone looks normal | Hormonal |
| SHBG | High SHBG binds testosterone, lowering the free, usable amount and shifting the balance | Hormonal |
| Prolactin | High prolactin suppresses testosterone and is a recognised cause of breast tissue growth | Hormonal |
| LH & FSH | The pituitary signals that show whether low testosterone starts in the testes or the brain | Hormonal |
| Thyroid (TSH) | An overactive thyroid raises oestrogen activity and is a treatable cause | Endocrine |
| Liver & kidney function | Liver disease and chronic kidney disease both disturb hormone clearance and balance | Organ function |
Helvy's Complete Male Hormones panel (£119) is built around this picture — it measures oestradiol, total and free testosterone, SHBG, LH, FSH, prolactin, DHEA-S and cortisol in a single sample. The narrower £99 Hormone Balance panel does not include oestradiol, which is the marker that matters most here, so for gynaecomastia the male panel is the right starting point. To add thyroid, liver and kidney function in the same sitting, pair it with the General Energy & Wellness panel (£149). Not sure which combination fits? The quick quiz below points you to the right starting panel.
4. Hormonal causes: testosterone, oestradiol, prolactin
Low testosterone. A fall in testosterone is one of the most common reasons the balance tips. As men age, testosterone tends to drift down while body fat and aromatase activity rise, which is why gynaecomastia becomes more common from middle age onward. The number alone can mislead, though — because most testosterone is bound to SHBG, a man with high SHBG can have a “normal” total testosterone and still be functionally low on the active fraction. Our guide to low testosterone symptoms and the testosterone levels by age chart put the numbers in context.
Raised oestradiol. Oestradiol is the oestrogen that does most of the work in men, and when it runs high relative to testosterone it stimulates the breast gland directly. It can rise with higher body fat, with some medications, and occasionally from a hormone-producing tumour, which is why a high reading is always interpreted in context rather than acted on alone. Our oestradiol blood test guide explains how the marker behaves in men and women.
Prolactin. Prolactin is the hormone behind breastfeeding, and men make it too. When it runs high it suppresses testosterone and is a well-recognised contributor to gynaecomastia and low libido. Persistently raised prolactin can point to a benign pituitary issue that is very treatable once identified, which is why it belongs on any thorough panel. Our prolactin blood test guide explains what high readings can mean.
5. Other causes: thyroid, liver, medication, steroids
Thyroid and organ function. An overactive thyroid increases oestrogen activity and is a recognised, reversible cause. Liver disease disturbs the way the body clears hormones, raising the proportion of oestrogen, while chronic kidney disease affects the same balance through different routes. This is why a sensible workup looks beyond the sex hormones to thyroid, liver and kidney markers — the picture the General Energy & Wellness panel adds.
Medications. A long list of common drugs can trigger breast tissue growth, including some blood pressure medicines (notably spironolactone and certain calcium-channel blockers), some prostate medications, anti-ulcer drugs, certain antidepressants and antipsychotics, and some treatments used in prostate cancer. The NICE Clinical Knowledge Summary on gynaecomastia keeps a medication review at the centre of assessment. Never stop a prescribed medicine on your own — raise it with the clinician who prescribed it.
Anabolic steroids and supplements. This is an important and often unspoken cause in younger men. Anabolic steroids and prohormones flood the body with androgens that are partly converted to oestrogen, frequently producing gynaecomastia — and the imbalance can persist after stopping. Recreational drugs including alcohol and cannabis are also linked. If any of these apply, an honest account to your clinician matters far more than any single blood result.
6. NHS pathway vs private testing
If you see your GP about breast tissue, the NICE pathway starts with an examination to confirm true glandular tissue, a medication and drug review, and — where the cause is not obvious — blood tests covering the sex hormones, liver and kidney function and thyroid. This is genuinely sound, and seeing a doctor matters because examination is what separates harmless from important.
In practice, the NHS panel can be narrower than the guidance suggests, and waits for endocrine bloods and an ultrasound can run to weeks. Many men get a partial set — testosterone without SHBG or free testosterone, or no oestradiol — and a single “normal” value can close the conversation before the balance has really been examined.
Private testing fills that gap. A comprehensive panel from one sample gives you oestradiol, total and free testosterone, SHBG, prolactin and the pituitary signals together, with results in days. The aim is not to bypass your GP but to walk in better informed — discussing results rather than requesting tests, so a qualified clinician can act on a fuller picture.
7. Red flags and what to do with your results
Most gynaecomastia is benign, and many cases that appear at puberty or with weight gain settle on their own or improve when the cause is addressed. Blood results are a starting point, not a verdict. If your hormones come back balanced and your organ markers are clear, that is reassuring and points attention toward body composition and any medications. If a marker flags — low free testosterone, raised oestradiol, high prolactin, abnormal thyroid or liver function — the next step is a conversation with a qualified clinician, not self-treatment. Your data suggests where to look; a clinician decides what it means for you.
See a doctor without delay if: the lump is on one side only, hard or fixed, growing quickly, or the skin or nipple has changed or is discharging — male breast cancer is rare but these are the features that need urgent assessment, and the NICE referral guidance treats them as a priority. Also see a doctor if breast growth comes on suddenly, is very tender, follows a new medicine, or appears alongside a testicular lump or swelling.
8. Frequently asked questions
Can a blood test diagnose gynaecomastia?
Gynaecomastia itself is diagnosed by examination — feeling the firm glandular tissue behind the nipple. What blood tests do is reveal the hormonal cause behind it, such as low testosterone, raised oestradiol or high prolactin, so it can be addressed at the root. A qualified clinician interprets the markers alongside your history and examination.
Which blood tests should I get for gynaecomastia?
A useful panel measures oestradiol, total and free testosterone, SHBG, prolactin, LH and FSH, together with thyroid, liver and kidney function. Testing them together lets a clinician read the balance between oestrogen and testosterone, rather than relying on any single value that might look normal in isolation.
Is gynaecomastia caused by low testosterone or high oestrogen?
It is usually about the balance between the two. Oestrogen stimulates breast tissue and testosterone restrains it, so the gland can grow when oestrogen rises, when testosterone falls, or when the ratio shifts. That is why both are measured together rather than one in isolation.
How do I tell gynaecomastia apart from chest fat?
True gynaecomastia is a firm, rubbery disc of tissue concentrated under the nipple, sometimes tender. Pseudogynaecomastia is soft fat spread evenly across the chest with no firm gland. A pinch test gives a clue, but a clinical examination is what confirms it, and the distinction changes what a blood test is looking for.
Should I fast before a gynaecomastia blood test?
A morning sample is more important than fasting for the hormones, because testosterone peaks before 10am. If the same panel also checks glucose, cholesterol and liver function, an overnight fast makes those read more accurately, so testing before 10am after an overnight fast, drinking only water, covers both.
Can gynaecomastia go away on its own?
Often, yes — pubertal gynaecomastia frequently settles within a year or two, and cases driven by a medication, body fat or another reversible cause can improve once that cause is addressed. Long-standing glandular tissue is less likely to resolve fully on its own, which is a reason to identify the cause early rather than wait.
See the hormonal balance, not just the symptom.
Gynaecomastia is worth understanding properly. Helvy's Complete Male Hormones panel tests 9 biomarkers including oestradiol, total and free testosterone, SHBG, LH, FSH and prolactin — the balance that drives breast tissue growth. Pair it with General Energy & Wellness to add thyroid, liver and kidney function, all from UKAS-accredited UK laboratories with results in days.
Related guides
Sources
- NHS. Gynaecomastia (enlarged breasts in men). nhs.uk
- NICE Clinical Knowledge Summaries: Gynaecomastia. NICE CKS
- Narula HS, Carlson HE. Gynecomastia: Clinical evaluation and management. Indian J Endocrinol Metab. PMC3987263
- Cuhaci N et al. / Johnson RE, Murad MH. Gynecomastia. StatPearls, NCBI Bookshelf. NBK430812
- NICE Guideline NG12: Suspected cancer — recognition and referral. NICE NG12
- Wu FCW et al. Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men (European Male Ageing Study). NEJM. PMC2701485